Comment
doi: 10.1210/clinem/dgab878.
Letter to the Editor From Malozowski: "Weekly Lonapegsomatropin in Treatment-naïve Children with Growth Hormone Deficiency: the Phase 3 heiGHt Trial"
Affiliations
- PMID: 34918085
- PMCID: PMC9016435
- DOI: 10.1210/clinem/dgab878
Item in Clipboard
Comment
Letter to the Editor From Malozowski: "Weekly Lonapegsomatropin in Treatment-naïve Children with Growth Hormone Deficiency: the Phase 3 heiGHt Trial"
J Clin Endocrinol Metab.
.
No abstract available
Comment in
-
Response to Letter to the Editor From Malozowski: "Weekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial".J Clin Endocrinol Metab. 2022 Apr 19;107(5):e2215-e2216. doi: 10.1210/clinem/dgab879. J Clin Endocrinol Metab. 2022. PMID: 34915563 Free PMC article. No abstract available.
Comment on
-
Weekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial.J Clin Endocrinol Metab. 2021 Oct 21;106(11):3184-3195. doi: 10.1210/clinem/dgab529. J Clin Endocrinol Metab. 2021. PMID: 34272849 Free PMC article. Clinical Trial.
Similar articles
-
Response to Letter to the Editor From Malozowski: "Weekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial".J Clin Endocrinol Metab. 2022 Apr 19;107(5):e2215-e2216. doi: 10.1210/clinem/dgab879. J Clin Endocrinol Metab. 2022. PMID: 34915563 Free PMC article. No abstract available.
-
Response to Letter to the Editor From L. Sävendahl et al: "Weekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial".J Clin Endocrinol Metab. 2022 Feb 17;107(3):e1333-e1334. doi: 10.1210/clinem/dgab738. J Clin Endocrinol Metab. 2022. PMID: 34626470 Free PMC article. No abstract available.
-
Letter to the Editor From Sävendahl et al.: "Weekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial".J Clin Endocrinol Metab. 2022 Jan 18;107(2):e888-e889. doi: 10.1210/clinem/dgab736. J Clin Endocrinol Metab. 2022. PMID: 34626473 Free PMC article. No abstract available.
-
Spotlight on Lonapegsomatropin Once-Weekly Injection and Its Potential in the Treatment of Growth Hormone Deficiency in Pediatric Patients.Drug Des Devel Ther. 2022 Jun 29;16:2055-2066. doi: 10.2147/DDDT.S336285. eCollection 2022. Drug Des Devel Ther. 2022. PMID: 35791404 Free PMC article. Review.
-
Growth hormone therapy in children with growth hormone deficiency.Acta Paediatr Taiwan. 2001 Sep-Oct;42(5):269-70. Acta Paediatr Taiwan. 2001. PMID: 11729701 Review. No abstract available.
Cited by
-
Response to Letter to the Editor From Malozowski: "Weekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial".J Clin Endocrinol Metab. 2022 Apr 19;107(5):e2215-e2216. doi: 10.1210/clinem/dgab879. J Clin Endocrinol Metab. 2022. PMID: 34915563 Free PMC article. No abstract available.
References
-
- Silverman BL, Blethen SL, Reiter EO, et al. . A long-acting human growth hormone (Nutropin Depot): efficacy and safety following two years of treatment in children with growth hormone deficiency. J Pediatr Endocrinol Metab. 2002;15(Suppl 2):715-722. - PubMed
-
- https://pink.pharmaintelligence.informa.com/PS044127/Nutropin-Depot-disc.... Accessed December 23, 2021.
-
- Amato G, Mazziotti G, Di Somma C, et al. . Recombinant growth hormone (GH) therapy in GH-deficient adults: a long-term controlled study on daily versus thrice weekly injections. J Clin Endocrinol Metab. 2000;85(10):3720-3725. - PubMed
-
- Iglay K, Cao X, Mavros P, Joshi K, et al. . Systematic literature review and meta-analysis of medication adherence with once-weekly versus once-daily therapy. Clin Ther. 2015;37(8):1813-1821.e1. - PubMed
